Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on INT 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthetic method for loteprednol etabonate intermediate using cost-effective 11α-hydroxy-ADD. Enhances supply chain reliability and reduces manufacturing costs for steroid APIs.
Advanced silica gel adsorption method enhances purity and yield for Dabigatran Etexilate intermediates. Reduces toxic solvent use and simplifies supply chain operations significantly.
Patent CN110407902B reveals a greener method for 17-deacetoxylation of steroids using organic bases, offering significant cost reduction and easier solvent recovery for pharmaceutical manufacturing.
Patent CN107686852B reveals a novel omega-transaminase route for moxifloxacin intermediates, offering high ee values and streamlined manufacturing for reliable pharmaceutical intermediate suppliers.
Novel synthesis of Prasugrel intermediate via alkylation and borylation. Offers high purity, reduced waste, and scalable manufacturing for global pharmaceutical supply chains.
Novel reduction method for Sofosbuvir intermediate avoiding column chromatography. High yield, scalable process for API manufacturing.
Novel pH-dependent resolution method for Isavuconazole Intermediate 4 offering high purity and reduced operational complexity for pharmaceutical supply chains globally.
Novel synthetic route for key pharmaceutical intermediate reduces cost and complexity. Reliable supplier offering scalable production and high purity specifications for global supply chains.
Patent CN110981863A details a novel route for Sofosbuvir intermediates using unique imidate donors, offering superior beta-selectivity and streamlined purification for API manufacturing.
Patent CN110511225B details a novel copper-catalyzed decarboxylative coupling for ibutinib intermediates, offering significant cost reduction and supply chain stability.
Novel synthesis route for dronedarone intermediates avoiding metal catalysts. Cost-effective scalable manufacturing for pharmaceutical supply chains.
Novel organometallic palladium method for Elagolix intermediate. Reduces steps, avoids mesyl chloride, ensures high purity for pharmaceutical supply chains.
Novel mesylate salt formation improves purity and yield. Reduces dimer impurities. Ideal for scalable pharma manufacturing.
High-yield sitagliptin intermediate preparation method patent analysis. Supply chain stability and cost optimization for pharmaceutical manufacturing partners.
Patent CN112159358B reveals a novel ketal-protected route for Elagolix intermediates, ensuring high purity and scalable supply chain reliability for global pharmaceutical partners.
Patent CN110981883B reveals a superior 2-step synthesis for Ticagrelor intermediates. Discover cost-effective manufacturing and reliable supply chain solutions for API production.
Patent CN109942514B details a cost-effective L-phenylalanine route for Atazanavir intermediates, offering high purity and scalable manufacturing solutions.
Patent CN113896655A reveals a telescoped toluene-based route for Vonoprazan intermediate, offering >99.5% purity and scalable manufacturing for global supply chains.
Novel cyanoacetic acid route for Ramelteon intermediate. High yield, low cost, scalable process for API manufacturing.
Patent CN118791551B details high-purity semaglutide dipeptide fragment synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates globally.